PNC Financial Services Group Inc. Sells 248 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Posted by on Jun 3rd, 2023

PNC Financial Services Group Inc. reduced its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Rating) by 1.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,042 shares of the medical instruments supplier’s stock after selling 248 shares during the quarter. PNC Financial Services Group Inc. owned 0.06% of LeMaitre Vascular worth $646,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of LMAT. Legal & General Group Plc lifted its holdings in LeMaitre Vascular by 0.4% in the second quarter. Legal & General Group Plc now owns 45,769 shares of the medical instruments supplier’s stock valued at $2,084,000 after acquiring an additional 200 shares during the period. Arizona State Retirement System increased its position in LeMaitre Vascular by 3.9% in the fourth quarter. Arizona State Retirement System now owns 5,577 shares of the medical instruments supplier’s stock worth $257,000 after buying an additional 208 shares in the last quarter. MML Investors Services LLC increased its position in LeMaitre Vascular by 4.4% in the third quarter. MML Investors Services LLC now owns 7,866 shares of the medical instruments supplier’s stock worth $399,000 after buying an additional 334 shares in the last quarter. Legacy Wealth Asset Management LLC increased its position in LeMaitre Vascular by 1.9% in the fourth quarter. Legacy Wealth Asset Management LLC now owns 18,395 shares of the medical instruments supplier’s stock worth $847,000 after buying an additional 340 shares in the last quarter. Finally, Captrust Financial Advisors increased its position in LeMaitre Vascular by 555.3% in the first quarter. Captrust Financial Advisors now owns 616 shares of the medical instruments supplier’s stock worth $29,000 after buying an additional 522 shares in the last quarter. 86.85% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

LMAT has been the subject of a number of analyst reports. StockNews.com initiated coverage on LeMaitre Vascular in a research report on Thursday, May 18th. They issued a “buy” rating for the company. Barrington Research upgraded LeMaitre Vascular from a “market perform” rating to an “outperform” rating and set a $62.00 price target for the company in a research report on Wednesday, May 3rd. Finally, Roth Capital reiterated a “neutral” rating on shares of LeMaitre Vascular in a research report on Tuesday, March 7th.

Insider Activity at LeMaitre Vascular

In related news, CEO George W. Lemaitre sold 94,900 shares of the stock in a transaction that occurred on Wednesday, May 3rd. The stock was sold at an average price of $63.48, for a total transaction of $6,024,252.00. Following the completion of the transaction, the chief executive officer now directly owns 2,413,613 shares of the company’s stock, valued at $153,216,153.24. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, CEO George W. Lemaitre sold 94,900 shares of the stock in a transaction that occurred on Wednesday, May 3rd. The stock was sold at an average price of $63.48, for a total transaction of $6,024,252.00. Following the completion of the transaction, the chief executive officer now directly owns 2,413,613 shares of the company’s stock, valued at $153,216,153.24. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director John A. Roush sold 7,500 shares of the stock in a transaction that occurred on Tuesday, May 9th. The shares were sold at an average price of $65.74, for a total value of $493,050.00. Following the transaction, the director now directly owns 8,669 shares of the company’s stock, valued at $569,900.06. The disclosure for this sale can be found here. Over the last three months, insiders sold 146,663 shares of company stock valued at $9,321,230. Insiders own 12.40% of the company’s stock.

LeMaitre Vascular Trading Up 1.4 %

NASDAQ:LMAT opened at $64.91 on Friday. LeMaitre Vascular, Inc. has a 12-month low of $40.82 and a 12-month high of $68.06. The stock has a 50-day moving average price of $57.40 and a 200 day moving average price of $50.88. The stock has a market capitalization of $1.44 billion, a P/E ratio of 69.80, a P/E/G ratio of 5.23 and a beta of 0.98.

LeMaitre Vascular (NASDAQ:LMAT – Get Rating) last released its earnings results on Tuesday, May 2nd. The medical instruments supplier reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.02. LeMaitre Vascular had a return on equity of 8.86% and a net margin of 12.20%. The firm had revenue of $47.08 million during the quarter, compared to analysts’ expectations of $43.54 million. During the same quarter last year, the business posted $0.27 earnings per share. The firm’s revenue was up 19.0% on a year-over-year basis. On average, research analysts predict that LeMaitre Vascular, Inc. will post 1.2 earnings per share for the current fiscal year.

LeMaitre Vascular Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 1st. Investors of record on Wednesday, May 17th were paid a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date of this dividend was Tuesday, May 16th. LeMaitre Vascular’s payout ratio is presently 60.22%.

About LeMaitre Vascular

(Get Rating)

LeMaitre Vascular, Inc engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy.

Featured Stories

Institutional Ownership by Quarter for LeMaitre Vascular (NASDAQ:LMAT)

Receive News & Ratings for LeMaitre Vascular Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LeMaitre Vascular and related companies with MarketBeat.com's FREE daily email newsletter.